Technical testing and analysis
ONCOGENE AS
Revenue 2024
NOK 644,000
Operating profit
NOK 201,000
Equity
NOK 1.1m
Incorporated
2020
Share capital
NOK 32,000
Roles
Daglig lederMorten Bjelke-Holtermann Duesund
Regnskapsfører
Styrets lederMorten Bjelke-Holtermann Duesund
StyremedlemIda Christine Filtenborg Hansen
StyremedlemTore Helge Rismyhr
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| MODUS I AS | 72.0% | 216.000000 | 2025 |
| ECONTO AS | 10.0% | 30.000000 | 2025 |
| IDA CHRISTINE FILTENBORG HANSEN | 5.0% | 15.000000 | 2025 |
| TORE HELGE RISMYHR | 5.0% | 15.000000 | 2025 |
| MAKRI INVEST AS | 5.0% | 15.000000 | 2025 |
| BINITA DEBNATH | 3.0% | 9.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.